Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Ludivine S. Breger
Based on 7 articles published since 2010
(Why 7 articles?)
||||
Expertise Level
The expertise of Ludivine S. Breger ranks in the
  • Top 3.8%
  • ... of 89,464 published authors worldwide on Parkinson Disease
  • ... from 2010 through 2020
  • ... based on contributions to 7 articles on the topic.
Graphical view (beta)
Aliases Breger, Ludivine S   ·   Breger, L S
Work Locations
Details
Most likely:    Lund University      
2019
  • CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 30531868
2018
  • CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Molecular Neuromodulation, Department of Experimental Medical Sciences, Lund University, Lund, Sweden. · Pubmed 30324128
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Wissenschaftskolleg zu Berlin, Institute for Advanced Study, Wallotstr. 19, D-14193, Berlin, Germany. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Institute of Pharmacy, Pharmacology and Toxicology, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria. · CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · CNRS, Institut des Maladies Neurodégénératives, University of Bordeaux, Bordeaux, France. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 29968767
2017
  • Wallenberg Neuroscience Center, Neurobiology Division, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden. · Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104. · Institute on Aging, University of Pennsylvania, Philadelphia, PA 19104. · Wallenberg Neuroscience Center, Neurobiology Division, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden; · Pubmed 28900002
Probable:    Universite de Bordeaux      
2018
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Wissenschaftskolleg zu Berlin, Institute for Advanced Study, Wallotstr. 19, D-14193, Berlin, Germany. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Institute of Pharmacy, Pharmacology and Toxicology, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria. · CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · CNRS, Institut des Maladies Neurodégénératives, University of Bordeaux, Bordeaux, France. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 29968767
Probable:    Centre National de la Recherche Scientifique      
2018
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Wissenschaftskolleg zu Berlin, Institute for Advanced Study, Wallotstr. 19, D-14193, Berlin, Germany. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Institute of Pharmacy, Pharmacology and Toxicology, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria. · CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · CNRS, Institut des Maladies Neurodégénératives, University of Bordeaux, Bordeaux, France. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 29968767
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Ludivine S. Breger in 2010-2020 about Parkinson Disease:

  • GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration. 2019
  • Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain. 2018
  • Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. 2018
  • Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. 2017
  • Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease. 2017
  • L-DOPA and graft-induced dyskinesia: different treatment, same story? 2013
  • Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats. 2012
Show List of Full Article Records
Google Searches

Learn more about Ludivine S. Breger using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Lund University
Universite de Bordeaux
Centre National de la Recherche Scientifique
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Lund University
2019
  • CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 30531868
2018
  • CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Molecular Neuromodulation, Department of Experimental Medical Sciences, Lund University, Lund, Sweden. · Pubmed 30324128
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Wissenschaftskolleg zu Berlin, Institute for Advanced Study, Wallotstr. 19, D-14193, Berlin, Germany. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Institute of Pharmacy, Pharmacology and Toxicology, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria. · CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · CNRS, Institut des Maladies Neurodégénératives, University of Bordeaux, Bordeaux, France. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 29968767
2017
  • Wallenberg Neuroscience Center, Neurobiology Division, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden. · Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104. · Institute on Aging, University of Pennsylvania, Philadelphia, PA 19104. · Wallenberg Neuroscience Center, Neurobiology Division, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden; · Pubmed 28900002
Universite de Bordeaux
2018
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Wissenschaftskolleg zu Berlin, Institute for Advanced Study, Wallotstr. 19, D-14193, Berlin, Germany. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Institute of Pharmacy, Pharmacology and Toxicology, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria. · CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · CNRS, Institut des Maladies Neurodégénératives, University of Bordeaux, Bordeaux, France. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 29968767
Centre National de la Recherche Scientifique
2018
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Wissenschaftskolleg zu Berlin, Institute for Advanced Study, Wallotstr. 19, D-14193, Berlin, Germany. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Institute of Pharmacy, Pharmacology and Toxicology, Center for Molecular Biosciences, University of Innsbruck, Innsbruck, Austria. · CNS Gene Therapy, Department of Experimental Medical Science, Lund University, Lund, Sweden. · CNRS, Institut des Maladies Neurodégénératives, University of Bordeaux, Bordeaux, France. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 29968767
Miscellaneous institutions in Cardiff
2017
  • School of Pharmacy & Pharmaceutical Sciences, Redwood Building, King Edward VII Avenue, CF10 3NB Cardiff, UK; Brain Repair Group, Cardiff School of Biosciences, Museum Avenue, CF10 3AX Cardiff, UK. Electronic address: · School of Pharmacy & Pharmaceutical Sciences, Redwood Building, King Edward VII Avenue, CF10 3NB Cardiff, UK. Electronic address: · Brain Repair Group, Cardiff School of Biosciences, Museum Avenue, CF10 3AX Cardiff, UK. Electronic address: · Brain Repair Group, Cardiff School of Biosciences, Museum Avenue, CF10 3AX Cardiff, UK. Electronic address: · School of Pharmacy & Pharmaceutical Sciences, Redwood Building, King Edward VII Avenue, CF10 3NB Cardiff, UK. Electronic address: · Pubmed 27864045
Cardiff University
2013
  • School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, CF10 3NB, UK. · Pubmed 23828589
2012
  • Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, Wales, UK. · Pubmed 22722025
Yearly article counts 01220001100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.